5. Treatment‐related mortality after MSD‐HSCT.
| Study | MSD‐HSCT |
| % (N affected of N evaluable) | |
| Bayever 1984 | 20 (7 of 35) |
| Führer 1998 | NR |
| Gratwohl 19811 | 42 (8 of 19) |
1Gratwohl 1981: Treatment‐related mortality not stated in article but implied by the authors of the present review as 3 patients died of graft failure and 5 patients died of GVHD in the MSD‐HSCT group; in general graft failure and GVHD are complications of HSCT.
Abbreviations: MSD‐HSCT: first‐line allogeneic hematopoietic stem cell transplantation from HLA‐matched sibling donor; N: number; NR: not reported